Toth Financial Advisory Corp Zoetis Inc. Transaction History

Toth Financial Advisory Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	BUY	$145.54 - $178.83 $2,474 - $3,040	17 New	17 $2,000
Q4 2023 Jan 26, 2024	SELL	$151.44 - $200.09 $151,742 - $200,490	-1,002 Reduced 28.1%	2,564 $506,000
Q3 2023 Oct 12, 2023	BUY	$167.14 - $192.77 $594,349 - $685,490	3,556 Added 35560.0%	3,566 $620,000
Q2 2023 Jul 24, 2023	SELL	$160.94 - $186.23 $8,851 - $10,242	-55 Reduced 84.62%	10 $1,000
Q1 2023 Apr 24, 2023	BUY	$145.48 - $175.02 $9,456 - $11,376	65 New	65 $10,000
Q3 2022 Oct 14, 2022	BUY	$148.29 - $182.55 $10,083 - $12,413	68 New	68 $10,000

1,957

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Toth Financial Advisory Corp, based on Form 13F filings with the SEC.

Stay updated on Toth Financial Advisory Corp with notifications on news.